Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration

被引:483
作者
Weibrich, G
Hansen, T
Kleis, W
Buch, R
Hitzler, W
机构
[1] Univ Mainz, Dept Prosthet, D-55131 Mainz, Germany
[2] Univ Mainz, Inst Pathol, D-55131 Mainz, Germany
[3] Univ Mainz, Dept Oral & Maxillofacial Surg, D-55131 Mainz, Germany
[4] Univ Mainz, Transfus Ctr, D-55131 Mainz, Germany
关键词
animal study; implant; platelet-rich plasma; thrombocyte; biological effect; histomorphometry;
D O I
10.1016/j.bone.2003.12.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study analyzed the effect of the platelet count in platelet-rich plasma (PRP) on bone regeneration in vivo. Twenty male New Zealand white rabbits were used. PRP was produced using the Platelet Concentrate Collection System (PCCS) (3i, Miami. FL. USA). After inducing ketamine-xylazine anaesthesia, a self-tapping titanium screw (Branemark MK III TiUnite, 3.75 x 7 mm) was inserted in each distal femur; the femurs were randomized so that one side was treated with PRP while the other (control) was not. Intravital fluorochrome staining was performed on days 1, 7 (1.5 ml of 2% doxycycline/kg bodyweight), 14 (6% xylenol orange, 1.5 ml/kg) and 21 (1% calcein green, 5 ml/kg). Animals were euthanized on day 28 (n = 20). Specimens were prepared for histomorphological evaluation according to Donath and Breuner [J. Oral Pathol. 11 (1982) 318]. Comparing the bone regeneration (fluorochrome staining) in the 4-week implants (n = 19), the only significant difference (sign test, P = 0.004) was seen with intermediate platelet concentrations (n = 9,503,000-1,729,000 platelets/mul PRP). There were no differences in the bone/implant contact rates between the test and the control side among the three groups. The platelet concentration required for a positive PRP effect on bone regeneration seems to span a very limited range. Advantageous biological effects seem to occur when PRP with a platelet concentration of approximately 1,000,000/mul is used. At lower concentrations, the effect is suboptimal, while higher concentrations might have a paradoxically inhibitory effect. On the other hand, the effect of this type of platelet concentrate was not beneficial to accelerate the osseointegration of enosseous dental implants. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:665 / 671
页数:7
相关论文
共 17 条
[1]   A METHOD FOR THE STUDY OF UNDECALCIFIED BONES AND TEETH WITH ATTACHED SOFT-TISSUES - THE SAGE-SCHLIFF (SAWING AND GRINDING) TECHNIQUE [J].
DONATH, K ;
BREUNER, G .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1982, 11 (04) :318-326
[2]   REGULATION OF MESANGIAL CELL-PROLIFERATION [J].
FLOEGE, J ;
TOPLEY, N ;
RESCH, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (06) :673-676
[3]   Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes [J].
Gruber, R ;
Varga, F ;
Fischer, MB ;
Watzek, G .
CLINICAL ORAL IMPLANTS RESEARCH, 2002, 13 (05) :529-535
[4]  
Kim SG, 2002, INT J ORAL MAX IMPL, V17, P86
[5]   CYTOSKELETON-DEPENDENT RELEASE OF HUMAN PLATELET EPIDERMAL GROWTH-FACTOR [J].
KIURU, J ;
VIINIKKA, L ;
MYLLYLA, G ;
PESONEN, K ;
PERHEENTUPA, J .
LIFE SCIENCES, 1991, 49 (26) :1997-2003
[6]  
LYNCH SE, 1999, TISSUE ENG
[7]   Platelet-rich plasma - Growth factor enhancement for bone grafts [J].
Marx, RE ;
Carlson, ER ;
Eichstaedt, RM ;
Schimmele, SR ;
Strauss, JE ;
Georgeff, KR .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1998, 85 (06) :638-646
[8]   Tumour-stromal interactions -: Transforming growth factor-β isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis [J].
Pollard, JW .
BREAST CANCER RESEARCH, 2001, 3 (04) :230-237
[9]  
SCHLEGEL KA, 2002, DTSCH ZAHNARZTL Z, V57, P194
[10]   Sinus floor augmentation with simultaneous placement of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1 -: A histometric study in miniature pigs [J].
Terheyden, H ;
Jepsen, S ;
Möller, B ;
Tucker, MM ;
Rueger, DC .
CLINICAL ORAL IMPLANTS RESEARCH, 1999, 10 (06) :510-521